
Andre C Kalil
Researcher
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
OCT 5
OCT 12
OCT 19
OCT 26
NOV 2
Jul 9, 2026
Sepsis - Beyond the guidelines
12:16
12:30
12:48
12:56
27:00

Sergio ZanottiHOST
In terms of why some patients with infections end up developing organ failure and sepsis and others don't, could you comment on the risk factors for this progression?

Andre KalilGUEST
I think that this is probably one of the most challenging factors that we have today because we've developed a lot of really incredible technology in terms of trying to understand the pathophysiology of these patients.

Andre KalilGUEST
We are still in the beginning of the learning curve, but I think we are starting to understand much better the situation.

Andre KalilGUEST
So there are several factors here that are critical for us to understand who is going to progress to a more severe picture of sepsis and septic shock compared to who is not.
14 MINS LATER

Sergio ZanottiHOST
What's the role of biomarkers and what is the current state of the art for diagnosis from your perspective?